A detailed breakdown for United States β including efficacy, cost, side effects, and how to get a prescription online.
Find Out Which Is Right for You βTirzepatide achieves meaningfully higher weight loss (~20β22% vs ~15%) due to its dual GLP-1 + GIP mechanism. If maximum weight loss is the priority and cost/coverage is not a barrier, tirzepatide is the stronger option. Semaglutide remains excellent with a longer safety record and better coverage.
βοΈ This comparison is for informational purposes only. Consult a licensed physician before choosing any medication. Individual responses vary.
Clinical data shows tirzepatide produces greater average weight loss (~20β22% vs ~15%). The SURMOUNT-1 trial demonstrated this superiority directly. However, individual responses vary significantly.
Mounjaro (tirzepatide) received Health Canada approval for type 2 diabetes. It is available through some telehealth providers, though coverage remains limited compared to semaglutide.
Both share similar GI side effects (nausea, diarrhea, constipation). Tirzepatide's side effect profile is comparable based on clinical trial data, though it appears to be slightly better tolerated by some patients.
Take our free quiz and get a personalized recommendation from a licensed United States physician.
Start Free Quiz β